USANA Health Sciences, Inc.
USNA
$17.05
-$0.09-0.52%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.40% | -68.74% | -38.06% | -43.67% | -34.11% |
| Total Depreciation and Amortization | 78.60% | 66.38% | 50.33% | 35.23% | 8.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.71% | -28.02% | -37.31% | -40.18% | -32.66% |
| Change in Net Operating Assets | -231.29% | -293.85% | 29.85% | 42.87% | 53.56% |
| Cash from Operations | -63.36% | -61.19% | -14.76% | -22.12% | -13.66% |
| Capital Expenditure | -37.23% | 17.73% | 17.88% | 37.93% | 30.50% |
| Sale of Property, Plant, and Equipment | 6,001.56% | -100.00% | 1,120.00% | 238.89% | 326.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -181.18% | -181.18% | -181.18% | -98.18% | -89.82% |
| Cash from Investing | 95.25% | -1,316.61% | -1,397.66% | -1,580.99% | -1,679.46% |
| Total Debt Issued | -25.70% | 1,560.90% | 1,558.53% | 1,013.52% | 1,436.12% |
| Total Debt Repaid | -1,713.22% | -1,569.65% | -1,566.06% | -95.60% | -95.60% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -135.68% | -134.71% | -22.90% | 39.74% | 13.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -525.03% | -144.72% | -24.47% | 130.60% | 167.10% |
| Foreign Exchange rate Adjustments | 182.53% | -177.18% | 155.22% | 76.56% | -147.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.36% | -479.14% | -661.67% | -554.30% | -454.76% |